|
Efficacy and Toxicity of Pemigatinib in Advanced Cholangiocarcinoma Harboring FGFR Fusions or Rearrangements: A Systematic Review and Meta-analysisAkkus E, Yasar HA, Rimassa L, Lamarca A
|
Liposomal irinotecan for previously treated patients with biliary tract cancer: A pooled analysis of NIFTY and NALIRICC trialsYoo C, Saborowski A, Hyung J, Wenzel P, Kim I, Wege H, Kim K, Folprecht G, Ryoo B, Schütt P, Cheon J, Götze T, Ryu H, Lee J, Vogel A
|
Deciphering the spatial tumor microenvironment in intrahepatic cholangiocarcinomaMacias RIR, Roessler S, Verstegen MMA
|
Mutational Analysis of Bile Cell-Free DNA in Primary Sclerosing Cholangitis: A Pilot StudyArechederra M, Bik E, Rojo C, Elurbide J, Elizalde M, Kruk B, Krasnodębski M, Pertkiewicz J, Kozieł S, Grąt M, Raszeja-Wyszomirska J, Rullan M, Alkorta-Aranburu G, Oyón D, Fernández-Barrena M, Candels L, Białek A, Krupa Ł, Schneider K, Urman J, Strnad P, Trautwein C, Milkiewicz P, Krawczyk M, Ávila M, Berasain C
|